undefined
products
推进创新化药原料药的开发与生产
原料药
主要生产兰索拉唑、泮托拉唑钠、雷贝拉唑钠等质子泵抑制剂（PPI）系列原料药及其中间体。
医药中间体
主要生产兰索拉唑、泮托拉唑钠、雷贝拉唑钠等质子泵抑制剂（PPI）系列原料药及其中间体。
CMO/CDMO
主要生产兰索拉唑、泮托拉唑钠、雷贝拉唑钠等质子泵抑制剂（PPI）系列原料药及其中间体。
走进北峰
厚朴远志，创新争先
辽宁北峰药业有限公司座落于中国药都—本溪市溪湖区石桥子香槐路65号，是江苏康缘药业集团旗下一家致力于原料药及中间体研发、生产和销售的药品生产企业。
企业愿景
成为绿色综合原料药生产基地
公司秉承集团“厚朴远志，创新争先”的企业价值观，在原PPI系列产品的基础上，开拓心脑血管、抗肿瘤、抗感染、糖尿病、减肥药、眼科用药、精神用药等多领域新药原料药的研发和生产，目前已经有异丙托溴铵、吡仑帕奈注册成功。
新闻中心
厚朴远志，创新争先
探索详情
Invitation to the 20th World Pharmaceutical Ingredients China (CPHI Shanghai) (December 16-18, 2020)
Thank you very much for your long-term support to our company, on the occasion of the 20th World Pharmaceutical Ingredients China Exhibition, we hereby sincerely look forward to your visit, and look forward to your arrival.
Project Name: Jinan Aisi Pharmaceutical Technology Co., Ltd (Shanghe Branch) Pharmaceutical APIs and ten kilograms of pharmaceutical APIs pilot platform project
According to the Environmental Impact Assessment Law of the People's Republic of China, Measures for Public Participation in Environmental Impact Assessment (Decree No. 4 of the Ministry of Ecological Environment) and relevant provisions of environmental impact assessment of construction projects, the construction of the project and environmental impact assessment is publicized in order to broadly understand the public's attitude towards the project and environmental protection opinions and suggestions, and accept public supervision.
Address: Room 2105, Building A, Building 1, Jinan Yaogu, North Section of Gangxing Third Road, High tech Zone, Jinan City
MOBILE WEBSITE
Copyright © 2023 Jinan Aisi Pharmaceutical Technology Co., Ltd
Powered by 300.cn